1 completed, 1 enrolling by invitation. 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Dr George Medvedev: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context Eptinezumab, Standard of Care - Migraine, Chronic Migraine | Phase 3 | Enrolling by invitation | Dr George Medvedev | 102 | 2025-05-05 | 2026-09-30 |
| Impact of Photobiomodulation on Objective, Physiological Measures of Brain Function in Individuals With Post-Concussion Syndrome BioFlex Dualport System, Sham device - Post-Concussive Syndrome, Chronic, Post-Concussion Syndrome | Not applicable | Completed | Dr George Medvedev | 19 | 2022-01-27 | 2024-05-29 |
Brain Concussion (1) · Emergencies (1) · Migraine Disorders (1) · Post-Concussion Syndrome (1)
Low-Level Light Therapy (1) · Standard of Care (1) · eptinezumab (1)
Canada (2)